Blackstone Group sold a portfolio of 93 life-science buildings to a separate fund the asset manager controls for $14.6 billion, in a transaction that represents a $6.5 billion gain in value from when it acquired the properties in 2016. The New York-based commercial real estate behemoth said that rather than cash out of the BioMed Realty Trust holdings, which is the second-largest owner of life science buildings in the U.S., investors opted to stay in,
source https://therealdeal.com/2020/10/16/blackstone-bets-big-on-life-science-buildings-with-14-6b-deal/
No comments:
Post a Comment